EGFR and oral cavity squamous cell carcinoma: In oral squamous cell carcinoma (OSCC), although GALNT2 expression can also modify the O-glycosylation of EGFR, it can facilitate the activation and downstream signaling of EGFR, thereby enhancing OSCC cell migration and invasion (Table 1) [92].